Neovacs SA (FR:ALNEV) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Neovacs SA has announced a fundraising initiative of €0.25 million through the issue of OCEANE-BSA securities to finance their Kinoïde research program and bolster investment in biotech and medtech projects. The fundraising could potentially create 500 million new shares, diluting current shareholders’ stakes. The company focuses on developing vaccine candidates and investing in high-potential biotech and medtech companies.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.